Cannabis use is associated with increased psychotic symptoms and poorer psychosocial functioning in first-episode psychosis: a report from the UK National EDEN Study
AuthorsSeddon, Jennifer L.
Jones, Peter B.
Singh, Swaran P.
MetadataShow full item record
AbstractOBJECTIVE: The use of cannabis during the early stage of psychosis has been linked with increased psychotic symptoms. This study aimed to examine the use of cannabis in the 12 months following a first-episode of psychosis (FEP) and the link with symptomatic course and outcome over 1 year post psychosis onset. DESIGN AND SETTING: One thousand twenty-seven FEP patients were recruited upon inception to specialized early intervention services (EIS) for psychosis in the United Kingdom. Participants completed assessments at baseline, 6 and 12 months. RESULTS: The results indicate that the use of cannabis was significantly associated with increased severity of psychotic symptoms, mania, depression and poorer psychosocial functioning. Continued use of cannabis following the FEP was associated with poorer outcome at 1 year for Positive and Negative Syndrome Scale total score, negative psychotic symptoms, depression and psychosocial functioning, an effect not explained by age, gender, duration of untreated psychosis, age of psychosis onset, ethnicity or other substance use. CONCLUSION: This is the largest cohort study of FEP patients receiving care within EIS. Cannabis use, particularly "continued use," was associated with poorer symptomatic and functional outcome during the FEP. The results highlight the need for effective and early intervention for cannabis use in FEP.
CitationSeddon JL, Birchwood M, Copello A, Everard L, Jones PB, Fowler D, Amos T, Freemantle N, Sharma V, Marshall M, Singh SP (2016) 'Cannabis use is associated with increased psychotic symptoms and poorer psychosocial functioning in first-episode psychosis: a report from the UK National EDEN Study', Schizophrenia Bulletin, 42 (3), pp.619-625.
PublisherOxford University Press (OUP)
PubMed Central IDPMC4838086
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Green - can archive pre-print and post-print or publisher's version/PDF
- Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.
- Authors: Rosengard RJ, Malla A, Mustafa S, Iyer SN, Joober R, Bodnar M, Lepage M, Shah JL
- Issue date: 2019 Jan 1
- Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
- Authors: Stone JM, Fisher HL, Major B, Chisholm B, Woolley J, Lawrence J, Rahaman N, Joyce J, Hinton M, Johnson S, Young AH, MiData Consortium.
- Issue date: 2014 Feb
- The impact of manic symptoms in first-episode psychosis: Findings from the UK National EDEN study.
- Authors: Marwaha S, Hett D, Johnson S, Fowler D, Hodgekins J, Freemantle N, McCrone P, Everard L, Jones P, Amos T, Singh S, Sharma V, Birchwood M
- Issue date: 2021 Oct
- Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
- Authors: Ouellet-Plamondon C, Abdel-Baki A, Salvat É, Potvin S
- Issue date: 2017 Oct
- Short-term outcome of substance-induced psychotic disorder in a large UK first episode psychosis cohort.
- Authors: Thompson A, Marwaha S, Winsper C, Everard L, Jones PB, Fowler D, Amos T, Freemantle N, Singh SP, Marshall M, Sharma V, Birchwood M
- Issue date: 2016 Oct